[HTML][HTML] Symptoms during outpatient cancer treatment and options for their management
Background Cancer patients account for a large segment of the German healthcare system,
with a 5-year prevalence of around 1.7 million persons. Advances in oncological treatment …
with a 5-year prevalence of around 1.7 million persons. Advances in oncological treatment …
Perspectives on palliative oxygen for breathlessness: systematic review and meta-synthesis
S Kochovska, DH Ferreira, MV Garcia… - European …, 2021 - Eur Respiratory Soc
Oxygen therapy is frequently prescribed for the palliation of breathlessness, despite lack of
evidence for its effectiveness in people who are not hypoxaemic. This study aimed to …
evidence for its effectiveness in people who are not hypoxaemic. This study aimed to …
[HTML][HTML] Controlled-release oxycodone vs. placebo in the treatment of chronic breathlessness—a multisite randomized placebo controlled trial
DH Ferreira, S Louw, P McCloud, B Fazekas… - Journal of pain and …, 2020 - Elsevier
Context Chronic breathlessness is a clinical syndrome that results in significant distress and
disability. Morphine can reduce chronic breathlessness when the contributing etiologies are …
disability. Morphine can reduce chronic breathlessness when the contributing etiologies are …
[HTML][HTML] The impact of unpredictability on dyspnea perception, anxiety and interoceptive error processing
Y Tan, O Van den Bergh, J Qiu… - Frontiers in …, 2019 - frontiersin.org
Dyspnea is a prevalent interoceptive sensation and the aversive cardinal symptom in many
cardiorespiratory diseases as well as in mental disorders. Especially the unpredictability of …
cardiorespiratory diseases as well as in mental disorders. Especially the unpredictability of …
Current pharmacological strategies for symptomatic reduction of persistent breathlessness–a literature review
DH Ferreira, S Kochovska, R McNeill… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Persistent breathlessness is a debilitating symptom that is prevalent in the
community, particularly in people with chronic and life-limiting illnesses. Treatment includes …
community, particularly in people with chronic and life-limiting illnesses. Treatment includes …
Predictive factors for the development of dyspnea within 7 days after admission among terminally ill cancer patients
R Matsunuma, T Yamaguchi, M Mori… - American Journal of …, 2022 - journals.sagepub.com
Background: Predictive factors for the development of dyspnea have not been reported
among terminally ill cancer patients. Objective: This current study aimed to identify the …
among terminally ill cancer patients. Objective: This current study aimed to identify the …
Prevalence and risk factors of breathlessness across Canada: a national retrospective cohort study in home care and nursing home populations
H Seow, P Dutta, MJ Johnson, K McMillan… - Journal of Pain and …, 2021 - Elsevier
Context Breathlessness is a symptom associated with poor clinical outcomes and prognosis.
Little is known about its long-term trends and associations with social factors including …
Little is known about its long-term trends and associations with social factors including …
Understanding persistent breathlessness: impact on patients and optimal approaches to symptomatic reduction–an overview
Introduction Persistent breathlessness (breathlessness persisting despite optimal treatment
for the underlying condition and resulting in disability) is a prevalent syndrome associated …
for the underlying condition and resulting in disability) is a prevalent syndrome associated …
[HTML][HTML] Tests to uncover and assess breathlessness: a proposed framework
M Ekström - Current Opinion in Supportive and Palliative Care, 2022 - journals.lww.com
Tests to uncover and assess breathlessness: a proposed frame... : Current Opinion in Supportive
and Palliative Care Tests to uncover and assess breathlessness: a proposed framework …
and Palliative Care Tests to uncover and assess breathlessness: a proposed framework …
Testosterone Levels in People Taking Regular Low-Dose Sustained-Release Morphine for Persisting Breathlessness: An Exploratory Study
DH Ferreira, M Ekström, B Fazekas… - Journal of Palliative …, 2023 - liebertpub.com
Background: The intermediate-and long-term effects of regular low-dose sustained-release
(SR) morphine on the testosterone levels of people with persistent breathlessness are …
(SR) morphine on the testosterone levels of people with persistent breathlessness are …